| abstract |
Scaffold compounds are used to design small molecule compounds to identify inhibitors of inflammation through structure-activity relationship studies. Methods include the use of small molecule compounds to inhibit, prevent and treat diseases and conditions associated with inflammation, including multiple sclerosis, Alzheimer's disease, acute myocardial infarction, traumatic brain injury, and autoinflammatory diseases. including pharmaceutical compositions. [Selection drawing] Fig. 1A |